Stress positron emission tomography is safe and can guide coronary revascularization in high-risk patients being considered for transcatheter aortic valve replacement

Journal of Nuclear Cardiology

Volumn 21, Issue 5, 2014, Pages 1001-1010

  Cremer, Paul C ^a   Khalaf, Shaden ^a   Lou, Junyang ^a   Rodriguez, Leonardo ^a   Cerqueira, Manuel D ^a   Jaber, Wael A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Aortic stenosis; coronary artery disease; myocardial blood flow; myocardial perfusion imaging; transcatheter aortic valve replacement

Indexed keywords

PURINE DERIVATIVE; PYRAZOLE DERIVATIVE; REGADENOSON; VASODILATOR AGENT;

ADVERSE EFFECTS; AGED; AORTIC VALVE STENOSIS; COMPLICATION; COMPUTER ASSISTED SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC USE; EXERCISE TEST; FEMALE; HUMAN; MALE; MYOCARDIAL PERFUSION IMAGING; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AORTIC VALVE STENOSIS; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HUMANS; MALE; MYOCARDIAL PERFUSION IMAGING; PERCUTANEOUS CORONARY INTERVENTION; POSITRON-EMISSION TOMOGRAPHY; PURINES; PYRAZOLES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURGERY, COMPUTER-ASSISTED; TRANSCATHETER AORTIC VALVE REPLACEMENT; VASODILATOR AGENTS;

EID: 84929941911     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-014-9928-y     Document Type: Article

References (29)

1. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 1997;29(3):630-4.
2. Kvidal P, Bergström R, Hörte L-G, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000;35(3):747-56.
3. Ortlepp JR, Schmitz F, Bozoglu T, Hanrath P, Hoffmann R. Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: An angiographic pair matched case-control study. Heart 2003;89(9):1019-22.
4. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation 2006;114(5):e84-e231.
5. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363(17):1597-607.
6. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364(23):2187-98.
7. Masson J-B, Lee M, Boone RH, Al Ali A, Al Bugami S, Hamburger J et al. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Cathet Cardiovasc Intervent 2010;76(2):165-73.
8. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366(18):1705-15.
9. McArdle BA, Dowsley TF, de Kemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? J Am Coll Cardiol 2012;60(18):1828-37.
10. Authors/Task Force Members. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33(19):2451-2496.
11. http://www.astellas.us/docs/lexiscan.pdf. Accessed March 26, 2014.
12. AlJaroudi W, Alraies MC, Hachamovitch R, Jaber WA, Brunken R, Cerqueira MD, et al. Association of left ventricular mechanical dyssynchrony with survival benefit from revascularization: A study of gated positron emission tomography in patients with ischemic LV dysfunction and narrow QRS. Eur J Nucl Med Mol Imaging 2012;39(10):1581-91.
13. Henzlova MJ, Cerqueira MD, Mahmarian JJ, Yao SS, Quality Assurance Committee of the American Society of Nuclear Cardiology, et al. Stress protocols and tracers. J Nucl Cardiol 2006;13:e80-90.
14. Ficaro EP, Lee BC, Kritzman JN, Corbett JR, et al. Corridor 4DM: The Michigan method for quantitative nuclear cardiology. J Nucl Cardiol 2007;14:455-65.
15. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation 2002;105:539-42.
16. Lortie M, Beanlands RSB, Yoshinaga K, Klein R, Dasilva JN, Dekemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging 2007;34(11):1765-74.
17. Samuels B, Kiat H, Friedman JD, Berman DS. Adenosine pharmacologic stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis: Diagnostic efficacy and comparison of clinical, hemodynamic and electrocardiographic variables with 100 age-matched control subjects. J Am Coll Cardiol 1995;25(1):99-106.
18. Patsilinakos SP, Spanodimos S, Rontoyanni F, Kranidis A, Antonelis IP, Sotirellos K, et al. Adenosine stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis. J Nucl Cardiol 2004;11(1):20-5.
19. Rajappan K, Rimolid OE, Durka DP, Ariff B, Pennell DJ, Sheridan DJ, et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 2002;105(4):470-6.
20. Burwash IG, Lortie M, Pibarot P, de Kemp RA, Graf S, Mundigler G, et al. Myocardial blood flow in patients with low-flow, low-gradient aortic stenosis: differences between true and pseudo-severe aortic stenosis. Results from the multicentre TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Heart 2008;94(12):1627-33.
21. Goel SS, Agarwal S, Tuzcu EM, Ellis SG, Svensson LG, Zaman T, et al. Percutaneous coronary intervention in patients with severe aortic stenosis: Implications for transcatheter aortic valve replacement. Circulation 2012;125(8):1005-13.
22. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32(8):1012-24.
23. Ling LF, Marwick TH, Flores DR, Jaber WA, Brunken RC, Cerqueira MD, et al. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: Inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging 2013;6(3):363-72.
24. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without pci for stable coronary disease. N Engl J Med 2007;356(15):1503-16.
25. https://ischemiatrial.org. Accessed March 26, 2014.
26. http://controlled-trials.com/ISRCTN75836930/75836930. Accessed March 26, 2014.
27. Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van’t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360(3):213-24.
28. Gould LK, Johnson NP, Bateman TM, Beanlands RS, Bengel FM, Bober T, et al. Anatomic versus physiologic assessment of coronary artery disease: Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol 2013;62:1639-53.
29. Yamamoto M, Hayashida K, Mouillet G, Chevalier B, Meguro K, Watanabe Y, et al. Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation. J Am Coll Cardiol Intv 2013;6(5):479-86.